New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
November 07, 2022 16:10 ET
|
Maravai LifeSciences Holdings LLC
SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and...
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
November 03, 2022 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to...
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
November 02, 2022 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
October 19, 2022 08:10 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Executive Chairman and former CEO of Maravai LifeSciences, Inc. (NASDAQ: MRVI) Carl Hull, has been reinstated as CEO of the company on an interim...
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
October 18, 2022 16:15 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans...
Maravai LifeSciences Announces CEO Leadership Transition
October 03, 2022 16:05 ET
|
Maravai LifeSciences Holdings LLC
William “Trey” Martin, III appointed to succeed Carl Hull as Chief Executive OfficerHull to Serve as Executive Chairman of the Board of Directors SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) --...
TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product
September 13, 2022 08:00 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI) and global provider of life science reagents and services,...
Maravai LifeSciences Announces September 2022 Investor Conference Schedule
August 15, 2022 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is...
CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results
August 04, 2022 16:51 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today, August 4th, by Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), please note that a...
Maravai Lifesciences Reports Second Quarter 2022 Financial Results
August 04, 2022 16:03 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...